MRI may help limit unnecessary prostate cancer biopsies in UK

An immediate MRI scan given to all men suspected of having prostate cancer may reduce the number of excessive biopsies by 28 percent, according to a March 19 article from The Telegraph.

Researchers from the University College London found MRI was 12 percent more likely to detect cancerous prostate tumors than a traditional biopsy. The findings, according to researchers, suggest MRIs may reduce biopsies in European men by more than a quarter million, according to the article. 

"In men who need to have investigation for prostate cancer for the first time, [the trial] shows that using an MRI to identify suspected cancer in the prostate and performing a prostate biopsy targeted to the MRI information leads to more cancers being diagnosed than the standard way that we have been performing prostate biopsy for the last 25 years," said lead author Veeru Kasivisvanathan, PhD, from the University of College London Division of Surgery and Interventional Science.  

Read the full story below:

MRI for all men suspected of prostate cancer could save thousands of lives - new study

""

A recent graduate from Dominican University (IL) with a bachelor’s in journalism, Melissa joined TriMed’s Chicago team in 2017 covering all aspects of health imaging. She’s a fan of singing and playing guitar, elephants, a good cup of tea, and her golden retriever Cooper.

Around the web

CCTA is being utilized more and more for the diagnosis and management of suspected coronary artery disease. An international group of specialists shared their perspective on this ongoing trend.

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.